Learn more on this topic: Managing the Continuum of Myeloid Malignancies (CML, MPN, MDS, and AML)

What are the indications of a germline predisposition in a patient with a known or suspected myeloid malignancy?

Jean Ridgeway, DNP, APN, NP-C, AOCN, and Andrew Artz, MD, on managing myeloid malignancies.

Copyright © 2010-2020 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.